Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients. En savoir plus sur Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.
Conditional survival after radical nephroureterectomy for upper tract carcinoma. En savoir plus sur Conditional survival after radical nephroureterectomy for upper tract carcinoma.
Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. En savoir plus sur Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort.
The feasibility of percutaneous renal cryoablation under local anaesthesia. En savoir plus sur The feasibility of percutaneous renal cryoablation under local anaesthesia.
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review. En savoir plus sur Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities. En savoir plus sur CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomy. En savoir plus sur International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomy.
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series. En savoir plus sur What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series.
Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer. En savoir plus sur Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey. En savoir plus sur Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.